My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 301

    1.

    Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit.

    Beyer AJ, Wang K, Umble AN, Wolt JD, Cunnick JE.

    Environ Health Perspect. 2007 Mar;115(3):354-60. Epub 2006 Dec 19.PMID: 17431483 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT).

    Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K.

    Transgenic Res. 2002 Oct;11(5):479-93.PMID: 12437079 [PubMed - indexed for MEDLINE]Related articles

    3.

    Analysis of immune response in young and aged mice vaccinated with corn-derived antigen against Escherichia coli heat-labile enterotoxin.

    Karaman S, Cunnick J, Wang K.

    Mol Biotechnol. 2006 Jan;32(1):31-42.PMID: 16382180 [PubMed - indexed for MEDLINE]Related articles

    4.

    Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli.

    Douce G, Giuliani MM, Giannelli V, Pizza MG, Rappuoli R, Dougan G.

    Vaccine. 1998 Jul;16(11-12):1065-73.PMID: 9682360 [PubMed - indexed for MEDLINE]Related articles

    5.

    Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.

    Mason HS, Haq TA, Clements JD, Arntzen CJ.

    Vaccine. 1998 Aug;16(13):1336-43.PMID: 9682399 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.

    de Haan L, Holtrop M, Verweij WR, Agsteribbe E, Wilschut J.

    Vaccine. 1996 Mar;14(4):260-6.PMID: 8744549 [PubMed - indexed for MEDLINE]Related articles

    7.

    Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine.

    Takahashi I, Kiyono H, Jackson RJ, Fujihashi K, Staats HF, Hamada S, Clements JD, Bost KL, McGhee JR.

    Infect Immun. 1996 Apr;64(4):1290-8.PMID: 8606092 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice.

    Bost KL, Holton RH, Cain TK, Clements JD.

    Immunology. 1996 Apr;87(4):633-41.PMID: 8675220 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.

    Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T.

    Vaccine. 2007 Feb 19;25(9):1647-57. Epub 2006 Nov 17.PMID: 17188785 [PubMed - indexed for MEDLINE]Related articles

    10.

    Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn.

    Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S.

    Vaccine. 2004 Oct 22;22(31-32):4385-9.PMID: 15474732 [PubMed - indexed for MEDLINE]Related articles

    11.

    Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.

    Verweij WR, de Haan L, Holtrop M, Agsteribbe E, Brands R, van Scharrenburg GJ, Wilschut J.

    Vaccine. 1998 Dec;16(20):2069-76.PMID: 9796066 [PubMed - indexed for MEDLINE]Related articles

    12.

    Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.

    Weltzin R, Guy B, Thomas WD Jr, Giannasca PJ, Monath TP.

    Infect Immun. 2000 May;68(5):2775-82.PMID: 10768972 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches.

    Nakagawa I, Takahashi I, Kiyono H, McGhee JR, Hamada S.

    J Infect Dis. 1996 Jun;173(6):1428-36.PMID: 8648216 [PubMed - indexed for MEDLINE]Related articles

    14.

    Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

    Clements JD, Hartzog NM, Lyon FL.

    Vaccine. 1988 Jun;6(3):269-77.PMID: 3048010 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recognition of a hepatitis B virus nucleocapsid T-cell epitope expressed as a fusion protein with the subunit B of Escherichia coli heat labile enterotoxin in attenuated salmonellae.

    Schödel F, Enders G, Jung MC, Will H.

    Vaccine. 1990 Dec;8(6):569-72.PMID: 1708183 [PubMed - indexed for MEDLINE]Related articles

    16.

    Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B.

    Lauterslager TG, Florack DE, van der Wal TJ, Molthoff JW, Langeveld JP, Bosch D, Boersma WJ, Hilgers LA.

    Vaccine. 2001 Mar 21;19(17-19):2749-55.PMID: 11257419 [PubMed - indexed for MEDLINE]Related articles

    17.

    Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.

    de Haan L, Verweij WR, Feil IK, Holtrop M, Hol WG, Agsteribbe E, Wilschut J.

    Immunology. 1998 Jul;94(3):424-30.PMID: 9767427 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine.

    Jones FR, Hall ER, Tribble D, Savarino SJ, Cassels FJ, Porter C, Meza R, Nunez G, Espinoza N, Salazar M, Luckett R, Scott D.

    Vaccine. 2006 May 1;24(18):3786-92. Epub 2005 Aug 30.PMID: 16343702 [PubMed - indexed for MEDLINE]Related articles

    19.

    Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin.

    Yamanaka H, Ishibashi D, Yamaguchi N, Yoshikawa D, Nakamura R, Okimura N, Arakawa T, Tsuji T, Katamine S, Sakaguchi S.

    Vaccine. 2006 Apr 5;24(15):2815-23. Epub 2006 Jan 17.PMID: 16446015 [PubMed - indexed for MEDLINE]Related articles

    20.

    Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

    Takahashi I, Marinaro M, Kiyono H, Jackson RJ, Nakagawa I, Fujihashi K, Hamada S, Clements JD, Bost KL, McGhee JR.

    J Infect Dis. 1996 Mar;173(3):627-35.PMID: 8627026 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity